SUNPHARMA Share Price, Analysis & Fundamentals

Despite strong fundamentals, the stock remains under pressure, reflecting a bearish trend and weak momentum ignored by the market.

The stock is currently navigating a bearish trend, with its price trading below key Exponential Moving Averages (EMAs) like the 9, 21, and 50-day periods. This technical setup suggests that recent price action has been weaker than the longer-term averages, indicating a potential downtrend that warrants caution.
Momentum appears to be waning, as evidenced by a Relative Strength Index (RSI) of 38.81, which is below the typical oversold threshold of 30, and a bearish Moving Average Convergence Divergence (MACD) signal. This suggests that buying pressure is subdued and selling pressure may be dominant.
Despite the bearish technical indicators, the company's fundamentals show resilience. Revenue for the latest quarter stood at ₹15,521 Cr, and importantly, both net profit and Earnings Per Share (EPS) have seen healthy year-over-year growth of over 16%. This indicates that the underlying business performance remains strong.
Analysts maintain a predominantly positive outlook, with a significant 88.89% of ratings falling into the 'Buy' or 'Strong Buy' categories. This consensus suggests that a majority of market experts believe the stock has good prospects, even amidst current technical weakness.
Shareholding patterns reveal a stable ownership structure, with promoters holding a substantial 54.48% stake. There was a minor shift in institutional holdings, with Domestic Institutional Investors (DIIs) increasing their stake by 0.28% while Foreign Institutional Investors (FIIs) slightly reduced theirs by 0.18%.

Short-term returns show a mixed picture with a negative 1-month return (-7.20%) but a positive 5-day return (0.79%).
The trend is bearish, indicated by a negative trend alignment score of -3 and the price being below key EMAs (EMA 9, 21, and 50).
Momentum is weak, with RSI at 38.81, below the oversold threshold, and a bearish MACD signal.
Volatility is moderate, with the price positioned at 20.23% of the Bollinger Bands width, and the band width is 10.15%.
The stock is trading 9.55% below its 52-week high and is within its maximum 1-year drawdown of -15.11%. The current drawdown is -9.55%. The price is 6.55% above its 52-week low.

The market behaviour indicates a bearish trend with weakening momentum. The price is trading below its key Exponential Moving Averages, and the Relative Strength Index (RSI) is in the lower range, suggesting subdued buying interest. While the stock is within its Bollinger Bands, it is positioned towards the lower end of the band's width. Structurally, the stock is trading below its 52-week high but above its 52-week low, and the current drawdown is within the historical maximum drawdown for the year. Volume analysis shows an average daily volume that is slightly above its 20-day average, with a positive delivery trend, suggesting some underlying accumulation despite the bearish technical signals.

The company reported a revenue of ₹15,521 Cr in the latest quarter.
Net profit saw a QoQ increase of 8.192% and a YoY increase of 16.066%.
EPS experienced a QoQ growth of 8.0% and a YoY growth of 16.033%.
Profit before tax increased by 1.416% QoQ and 21.605% YoY.